# MindMaze

the Swiss company, originally built around VR-based post-stroke neurorehabilitation, continued its European clinical expansion in 2026 by enrolling first patients in the SwissNeuroRehab high-dose, high-intensity neurorehabilitation study and launching the REACT-AVC study at Hospices Civils de Lyon;…

Source: https://en.bioecon.ru/companies/mindmaze/
Updated: 2026-08-15

- Country: Switzerland

## Technologies

- [Consumer neurotech & wellness BCI / EEG](https://en.bioecon.ru/technology/consumer-neurotech-wellness-bci-eeg/)
